Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Oryzon Genomics SA banner

Oryzon Genomics SA
LSE:0RDB

Watchlist Manager
Oryzon Genomics SA Logo
Oryzon Genomics SA
LSE:0RDB
Watchlist
Price: 2.742 EUR -1.51% Market Closed
Market Cap: €219.1m
Write Note Create Alert Ask AI

Wall St Price Targets

0RDB Price Forecast
Based on 8 analysts

+124% Upside
from €2.742 today

0RDB Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for 0RDB yet.

Oryzon Genomics SA Competitors:
Price Targets

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-43%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-43%
Average Miss

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-41%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-41%
Average Miss

What are analyst estimates?

Continue 0RDB Research

Summary
0RDB intrinsic value, competitors valuation, and company profile.
DCF Valuation
0RDB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
0RDB stock valuation using valuation multiples.
Wall St Estimates
0RDB price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
0RDB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Oryzon Genomics SA listings:
OTC • USD
ORYZF
 F • EUR
ORN
 MAD • EUR
ORY
 SWB • EUR
ORN
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 0RDB's stock price target?
Price Target
6.142 EUR

According to Wall Street analysts, the average 1-year price target for 0RDB is 6.142 EUR with a low forecast of 4.257 EUR and a high forecast of 12.645 EUR.

Back to Top
ALPHA SPREAD
Follow us
Join 358,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.